GlassScriptPhysician profile
Robert Steven Gerhard
NPI 1134562630
$954.78
in general payments reported to CMS, 2019-2025
17 companies · $36.93 in 2025
The $36.93 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $126 · 2021: $75.90 · 2022: $385 · 2023: $195 · 2025: $36.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $232.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $133.66 | 2022 | |
| Astellas Pharma US INC | $97.51 | 2019-2022 | |
| Ethicon US, LLC | $91.16 | 2020 | |
| Procept Biorobotics Corporation | $88.74 | 2020-2022 | |
| Myovant Sciences INC. | $87.41 | 2022 | |
| 180 Medical, INC. | $79.45 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $55.23 | 2023 | |
| C. R. Bard, INC. & Subsidiaries | $54.67 | 2023 | Bard Urinary Drainage Bag |
| Sumitomo Pharma America, INC. | $49.63 | 2023 | Gemtesa, Orgovyx |
| Boston Scientific Corporation | $41.77 | 2019-2025 | General - Kidney Stone Disease |
| Laborie Medical Technologies Corp. | $35.66 | 2023 | |
| Urovant Sciences INC | $30.44 | 2022 | |
| Endo Pharmaceuticals INC. | $30.42 | 2019-2020 | |
| Janssen Biotech, INC. | $24.16 | 2022 | |
| Teleflex LLC | $22.14 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Profound Medical Corp. | $17.47 | 2025 | Tulsa-Pro |
| Pfizer INC. | $15.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Gerhard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.